Some bosses stretch you. Others make work more bearable. Both can earn your loyalty. Only one is building your future. Leadership coach Angela Justice explains how to tell the difference.
As Daré Biosciences approaches a pivotal year with a key product launch ahead, the company kicked off an open public offering, providing a chance for individuals to get involved for as little as $250.
In the current geopolitical and capital-market uncertainty, biotechs that have not mastered the basics are the ones struggling the most. Here’s how—and why—to get the details right.
The Institute of Internal Auditors is enhancing its Certified Internal Auditor Challenge Exam with a new experienced-based pathway pilot and updates for Global Internal Audit Standards.
Reducing disputes is not about chasing collections more aggressively. It’s about designing billing processes for how work is performed and revenue is recognized.
Artifact announced the launch of its new Omni agentic workflow solution meant to help firms orchestrate complex, multi-system and cross-platform work via describing the workflow in plain language.
The acquisition of Tubulis GmbH—Gilead Sciences’ latest of the year after buying Arcells and Ouro Medicines—brings into the fold a novel ovarian cancer candidate that has demonstrated promising mid-stage data.